NCI's Gong Xingfeng Reports Strong Start in Dividend Insurance Transition, 2026 Focus on Expanding Product Portfolio

Deep News
03/30

On March 30, NCI held its 2025 annual results presentation. President and Chief Financial Officer Gong Xingfeng stated that the company firmly advanced its dividend insurance transition in 2025, successfully achieving a favorable start, primarily reflected in breakthroughs at the sales level.

Gong Xingfeng emphasized that 2025 marks only the beginning of the dividend insurance transition. In 2026, the company will continue to deepen this transformation, with a key focus on broadening product types, increasing sales efforts for risk annuities, and strengthening product innovation. The company plans to capitalize on the policy benefits for dividend health insurance, enhance product suitability management, adhere to selling appropriate products to suitable customers, and resolutely avoid sales misconduct.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10